Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Obesity, Cardiac MRI Structure and Non-ischaemic Cardiomyopathy
Author(s): Long Peng , Tao Zeng , Enxi Quan , et al Added: 1 year ago

Cardiovascular Kidney Metabolic

Heart Failure
Obesity and CKD: The Dual Epidemic in Cardiovascular Health
Author(s): Christopher Henry Grant , Samira Bell Added: 7 months ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Challenges of Treating Specific CV Disease in Patients With Obesity
Author(s): Naveed Sattar , Linda Mellbin , Neha Pagidipati , et al Added: 1 year ago
In the second session of Advancements in Obesity Management (AOM) 2024, the panel delve into treatment of specific CV diseases in patients living with obesity. Key co-morbidities discussed includediabetes, hypertension, dyslipidemia and thrombosis. View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Managing Obesity in HF: 2025 ACC Scientific Statement
Author(s): Michelle Kittleson Added: 11 months ago
In this short interview, we are joined by Dr Michelle Kittleson (Cedars-Sinai Heart Institute, US) to discuss the key updates and recommendations from the 2025 ACC Scientific Statement on the Management of Obesity in Adults with Heart Failure.Interview Questions:1. What is the current research landscape for heart failure patients with obesity?2. What are the new recommendations in this scientific… View more

Cardiovascular Kidney Metabolic

Heart Failure
Obesity in Focus: Implications for Heart Failure, Kidney Disease, and Pharmacology
Author(s): Chim C Lang , Bianca Rocca , Samira Bell Added: 8 months ago
In this short discussion, join Prof Chim Lang (University of Dundee, Dundee, UK), Guest Editor of the upcoming Special Focus on Obesity in Focus, Prof Bianca Rocca (LUM University, Casamassima, IT) and Dr Samira Bell (University of Dundee, Dundee, UK) to discover the implications of obesity on heart failure, kidney disease, and pharmacology.This conversation sets the stage for the upcoming… View more

Cardiovascular Kidney Metabolic

Heart Failure
Obesity in the Asia-Pacific Region: Current Perspectives
Author(s): David Tak Wai Lui , Junya Ako , Jamshed Dalal , et al Added: 2 years ago

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
New Horizons in Obesity Management 2026
Start date: Jun 17, 2026 End date: Jun 17, 2026
New Horizons in Obesity Management is a free-to-access, one-day virtual educational event on 17 June 2026.The event examines obesity as a central driver of cardio-renal-metabolic disease and a core contributor to multimorbidity across organ systems, and explores modern obesity pharmacotherapy as a potential disease-modifying intervention. New for 2026, the programme introduces three track-based… View more

Cardiovascular Kidney Metabolic

Prevention & Chronic Conditions
Glucagon-Containing Dual and Triple Agonists For Obesity and MASH
Author(s): Scott Harris Added: 1 year ago
In this short interview, Dr Scott Harris (Chief Medical Officer of AltImmune Inc.) joins us to discuss the emerging role of glucagon-containing dual and triple agonists for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). Dr Harris discusses the clinical need for these drugs, as well as an outline of the current evidence for the use of incretins in the… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Obesity, Nutrition & Mortality in Acute Heart Failure
Author(s): Mohammed El-Sheikh Added: 12 months ago
In this short interview, Dr Mohammed El-Sheikh discusses the key findings and clinical relevance of his recently published article, “Associations of Obesity and Prognostic Nutritional Index on 1-Year Mortality in Patients with Acute Heart Failure.” View more

Cardiovascular Kidney Metabolic

Heart Failure
Is Obesity Management Crucial for Ablation Success?
Author(s): Kyaw Z Win , Matthew J Armstrong , Richard P Steeds , et al Added: 1 year ago

Electrophysiology & Arrhythmia